Interleukin (IL)-18 is an important mediator of innate and adaptive immunity. We searched for an association of IL-18 promoter single-nucleotide polymorphisms (SNP) with rheumatoid arthritis (RA) in Caucasians. The entire study population was composed of two independent cohorts from Germany (n ¼ 200) and Scotland (n ¼ 410). Presence of IL-18 SNP at positions À607 and À137 was determined by allele-specific PCR in 327 RA patients and 283 healthy donors (HD). Diplotype distributions of both loci were in Hardy-Weinberg equilibrium (HWE) in the German and Scottish HD cohorts. In contrast, locus À607 was in HW disequilibrium in German, and locus À137 in Scottish RA patients. Diplotypic exact w 2 tests suggested that À607CC was overrepresented in German, and À137CC in Scottish RA patients, but conservative w 2 trend analyses could not prove any significant disease association of these single loci. SNP À607 and À137 were in strong linkage disequilibrium. The À607C*À137C haplotype was more prevalent in German RA (3.2 vs 1.2%) and in Scottish RA patients (4.1 vs 0.9%) than in the respective HD cohorts. These observations suggest that SNP of both positions contribute to the genetic background of RA pathogenesis.
Introduction
Rheumatoid arthritis (RA) is a common inflammatory joint disease associated with progressive joint destruction and functional decline. Both, genetic and environmental factors are considered to contribute to the incidence and severity of RA worldwide. 1 Twin concordance rate analyses and recently genome scan analyses give important insights into the genetic background of RA. [2] [3] [4] [5] [6] The QK(R)RAA shared epitope that is present in HLA DRB1*0401, DRB1*0101, and DRB*0404 genotypes is associated with the occurrence of RA, extraarticular manifestations, and a more severe course of RA. 7 This observation is suggestive of an important role for adaptive immune processes, and in particular for the interaction of antigen presenting and T cells in RA pathogenesis. Beside the regulatory IL-10, 8 which appears to modulate disease severity of RA on a genetic basis, many attempts have been made subsequently to elucidate the contribution of polymorphisms in genes encoding proinflammatory mediators, among them the inflammatory mediators interferon-gamma (IFN-g) and tumor necrosis factor-alpha (TNF-a). Despite numerous data at the protein and cellular level implicating these cytokines in RA pathogenesis, genetic polymorphism analyses and their functional consequences have proven contradictory. [9] [10] [11] [12] [13] We have speculated that cytokine genes that regulate a Th1 dominant pathway may associate with RA. In particular, we have focused on the innate response cytokine interleukin (IL)-18.
IL-18 is an important proinflammatory mediator of innate and acquired immune responses. 14 Together with IL-12 or IL-15, IL-18 is a potent enhancer of IFN-g expression in T cells, and in an inflammatory environment, it is also a stimulus for TNF-a expression in macrophages. 15 IL-18 also promotes neutrophil activation, 16 endothelial proliferation and blood vessel formation. 17 IL-18 is expressed in RA synovium with an excess of IL-18 bioactivity over the IL-18-binding activity of endogenous IL-18 antagonists. 18 IL-18, IFN-g and IL-18-binding protein (IL-18BP) are included in an important regulatory feedback loop that links macrophages, T cells and fibroblast-like synoviocytes. 19 IL-18 targeting in arthritis models leads to amelioration of inflammatory disease activity suggesting these observations have real significance.
IL-18 promoter polymorphism has been noted associated with various inflammatory diseases. [20] [21] [22] [23] The IL-18 promoter and IL-18 gene represent attractive candidate regions for gene polymorphism analyses in RA given its functional role in synovitis. Therefore, we have utilized two independent cohorts of Caucasian RA patients and healthy donors (HD) for polymorphism association analysis.
Results
For having the opportunity of a prospective analysis, the À607 and À137 allele and diplotype frequencies were first analyzed in separate for both investigated cohorts (Tables 1 and 2 ). The German cohort was used to generate, and the Scottish cohort for testing the obtained hypotheses. 
German cohort
Linkage of À607 and À137 loci Cross-sectional diplotype analyses revealed a strong linkage (Po0.0001) of À607AA with À137CC, and of À607CC with À137GG, respectively, independent of the population and the health state (Table 3 ). In addition, the À607AC diplotype was frequently associated with À137CG and À137GG. The À607*À137 haplotype Values are the number (percent). Values are the number (percent).
IL-18 SNP in rheumatoid arthritis JA Gracie et al analyses gave further evidence for a linkage of the single nucleotide polymorphisms (SNP), with a normalized two loci linkage disequilibrium coefficient D 0 of 0.846 for the entire study cohort (Table 4) .
Disease association of haplotypes
We found a significant overall marker trait association of haplotypes with the health state in the German cohort, in the Scottish cohort, and in the pooled data set. Haplotype trend regression (HTR) analyses revealed a significant association of À607C*À137C with RA in the Scottish and in the pooled data set, while À607A*À137G appeared to be protective in the German cohort. À607C*À137C was also more frequent in German RA than HD, but this association failed statistical significance due to the low total prevalence of this haplotype (3.2 in RA vs 1.2% in HD).
The À607*À137 genotype frequencies were only determined for the pooled data set ( 
Discussion
The present study addressed the prevalence of À607 and À137 IL-18 promoter SNP in Caucasian RA patients. A protective effect of the À607AA diplotype was recently postulated in a case-control study of Asian RA patients, and an influence of IL-18 promoter polymorphisms on the occurrence of different inflammatory and autoimmune diseases was also suggested by several other casecontrol studies. [20] [21] [22] [23] Our data of two separate Caucasian cohorts from Germany and Scotland showed divergent disease associations on the single-locus diplotype level, which need to be interpreted with caution in respect of the HW disequilibria observed in the respective RA cohorts. Moreover, the analyses of the compound data set were complicated by departure from HWE also in healthy controls, which was on a first glance suggestive for typing errors. This suspicion appears as far as possible excluded by use of two independent techniques in many subjects, which gave absolutely identical results, and also by the successful use of the same method in other studies. [21] [22] [23] [24] [25] Among more theoretical explanations as genetic selection, a stratification effect by composing our two independent cohorts has to be considered here. Departure from HWE, however, required a more conservative statistical calculation of allele and diplotype associations by trend tests, which, in contrast to the exact genotype w 2 tests, failed statistical significance for both single loci.
IL-18 is a putative target in several immune-mediated inflammatory diseases, among them RA, Crohn's disease, or autoimmune diabetes.
14 RA is a polygenic disease, with an obvious functional contribution by many proinflammatory and regulatory mediators. IL-18 displays several biological activities that render it a plausible candidate target for treatment of RA synovitis. However, little is yet known about those factors that regulate IL-18 expression in RA. Different variations in We have chosen to report the positions À607 (rs187238) and À137 (rs1946518), 24 which are identical to positions À640 and À170 defined in another publication. 20 Recent studies in a Polish cohort showed an important contribution of À137C and À137CC to the genetic risk in type I diabetes, and possibly a protective effect of À607AA. 21 In a Japanese study, a distinct genotype of À607A in combination with six other SNPs and a 9 bp insertion upstream from À607 was reported to be strongly associated with adult onset Still's disease (AOSD), and also to a lesser degree with RA. 20 The À137C/G polymorphism, however, was not detected in this cohort. 20 SNP in À137 was in contrast described in another Asian population, but showed no impact on the occurrence of RA. 22 Although these data of various case-control studies are not absolutely conclusive and require some further confirmation in independent cohorts and populations, the overall impression is still indicative of a functional importance for IL-18 promoter polymorphisms for the development of autoimmune diseases.
IL-18 expression in mice is strongly inducible through exogenous stimuli, for example, lipopolysaccharide (LPS) that was initially used to isolate IL-18 as an IFN-g inducing factor. 26 Expression of human IL-18 can to some extent be induced by TNF-a, 15 Gram positive bacteria, 27 histone deacetylase inhibitors, 28 and corticosteroids, 29 but appears rather constitutive when compared with murine IL-18. Stimulation with LPS in vitro did not change the level of human IL-18 mRNA or protein expression in peripheral blood mononuclear cells (PBMC), 28, 30 or human U937 promonocytic cell lines. This provides rational basis on which to explore the upstream genetic pathways that could sustain IL-18 expression in synovium.
While the translated exons of murine and human IL-18 share similar sequences resulting in similar protein structure and function, it became obvious that their expression is species-specific differently regulated. Basis for this are structural differences of the IL-18 promoter: 31, 32 The expression of murine IL-18 gene is regulated by at least two distinct promoters, promoter 1 and promoter 2, which are located in the 5 0 flanking region of the untranslated exon 1 and upstream region of exon 2, respectively. In contrast, human IL-18 gene contains only one untranslated exon. The sequence alignment with the proximal 5 0 flanking region of the human IL-18 and murine promoter 2 revealed a high degree of homology (72%). Initial functional analyses showed the À137C-607A haplotype being characterized by lower basal and mitogen induced promoter activity when compared with À137GÀ607A or À137CÀ607C. Besides the transcriptional regulation, post-translational modifications also appear relevant for the control of IL-18 bioactivity. 33 The two SNP analyzed here are obviously not randomly allocated to each other, which may have yet unknown functional consequences. It is also possible that some of the diplotypes associated with autoimmunity and inflammation have similar functional consequences, although the results of genetic case-control studies are to some extent different. The observed linkage of À607 and À137 alleles, and the similar disease association of the IL-18 promoter haplotypes in our two independent Caucasian cohorts despite differences on the single-locus level suggest that both loci are of pathogenic importance. The reported association of rather rare À607*À137 genotypes with RA in our compound data set has to be confirmed in an independent study. At this time, it is still unknown whether the suggested disease risk depends on the À607 and À137 promoter sites itself or another linked locus. The functional consequences of IL-18 promoter polymorphisms require further investigation.
Patients and methods
Two previously described IL-18 promoter polymorphisms (NCBI SNP accession number rs187238 in position À607, and rs1946518 in position À137 5 0 from the transcription start site 24 ) were analyzed in two independent Caucasian cohorts from Germany and the United Kingdom (West of Scotland). A total of 77 female and 25 male patients with unequivocal RA meeting ACR classification criteria, 34 and 98 unrelated healthy subjects comprise the German cohort. The median age of healthy controls was 46 years (range 34-64), and 59 years (range 23-79) for the RA patients. The gender distribution was PBMC were separated by Ficoll Hypaque density centrifugation. DNA was extracted using the QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany). Sequence-specific PCR was performed for position À607 with a common reverse primer 5 0 -TAA CCT CAT TCA GGA CTT CC-3 0 , a control forward primer 5 0 -CTT TGC TAT CAT TCC AGG AA-3 0 resulting in a 301 bp fragment as an internal amplification control, and the two allele-specific forward primers 5 0 -GTT GCA GAA AGT GTA AAA ATT ATT AC-3 0 and 5 0 -GTT GCA GAA AGT GTA AAA ATT ATT AA-3 0 (each with a 196 bp amplification product). Hybridization of primers was performed at 571C for 40 s, and amplification was with 25 PCR cycles. For position À137, the common reverse primer was 5 0 -AGG AGG GCA AAA TGC ACT GG-3 0 , the control forward primer was 5 0 -CCA ATA GGA CTG ATT ATT CCG CA-3 0 (resulting 446 bp amplicon), the allele-specific forward primers were 5 0 -CCC CAA CTT TTA CGG AAG AAA AG-3 0 and 5 0 -CCC CAA CTT TTA CGG AAG AAA AC-3 0 (amplicon size 261 bp). Hybridization temperature was 621C. Amplification products were stained with ethidium bromide and visualized on a UV transilluminator. The methods are described in detail in Giedraitis et al. 24 Statistical analyses were performed by SPSS s program package (SPSS, Munich, Germany) and PowerMarker V3.0 (http://statgen.ncsu.edu). The frequency of alleles and diplotypes was calculated in RA patients and healthy controls and given as the number and percentage of the entire data set. Statistical significance of obtained results was estimated by single-locus case-control test, which includes the allele and diplotypic case-control and multiallelic trend test. HWE was calculated for each single cohort, the compound RA and HD cohorts, and the entire data set by w 2 test. Association of diplotypes and of the distinct genotypes was estimated by w 2 test. The disease association of haplotypes was calculated by haplotype trend regression analysis. Haplotype frequencies were estimated by calculating the EM algorithm. In order to perform a HTR from the estimated probabilities of haplotypes, a data set was created containing the probability for each possible haplotype within an individual. This data set was analyzed by Stepwise Logistic Regression using SPSS 
